Eastend Director Park Chung Sung Discloses 1.14% Stake
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
HGTECH Q3 net profit rises 17.03% year over year
M impact | EQUITY | Oct 29, 2026, 12:54 PM UTC
Donegal Group Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 29, 2026, 12:54 PM UTC
Inner Mongolia Yili Q3 Net Profit Falls 5.6% Y/Y
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
GATX Reports Third-Quarter Results
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
Shengyi Technology Q3 Net Profit Rises 238.4% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
Processa Pharmaceuticals Reports FDA Clearance for VT-7208 Phase 2 Study
Processa Pharmaceuticals reported FDA clearance for a Phase 2 study of VT-7208, a new pipeline collaboration and the appointment of Sheila Gujrathi as Executive Chair.
L impact | EQUITY | Oct 29, 2026, 12:53 PM UTC